GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Guaifenesin And Dextromethorphan Hydrobromide patents expire, and when can generic versions of Guaifenesin And Dextromethorphan Hydrobromide launch?
Guaifenesin And Dextromethorphan Hydrobromide is a drug marketed by Actavis Labs Fl, Amneal Pharms, Aurobindo Pharma, Dr Reddys, Perrigo R And D, and Sun Pharm. and is included in six NDAs.
The generic ingredient in GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE is dextromethorphan hydrobromide; guaifenesin. There are twenty-three drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; guaifenesin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?
- What are the global sales for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?
- What is Average Wholesale Price for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?
Summary for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 59 |
| What excipients (inactive ingredients) are in GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE? | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE excipients list |
| DailyMed Link: | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE at DailyMed |
Pharmacology for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
| Drug Class | Expectorant Sigma-1 Agonist Uncompetitive N-methyl-D-aspartate Receptor Antagonist |
| Mechanism of Action | Sigma-1 Receptor Agonists Uncompetitive NMDA Receptor Antagonists |
| Physiological Effect | Decreased Respiratory Secretion Viscosity Increased Respiratory Secretions |
US Patents and Regulatory Information for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 091070-001 | Aug 31, 2015 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 217340-001 | Aug 1, 2023 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Amneal Pharms | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 209692-002 | Nov 1, 2018 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
